Condition: Venous Thromboembolism · Sponsor: Ottawa Hospital Research Institute
This trial seeks to assess the feasibility of a full-scale, double-blind, placebo-controlled, randomized trial assessing whether low-dose colchicine (0.5 mg daily) reduces the risk of post-thrombotic syndrome (PTS) in patients with proximal lower extremity deep vein thrombosis (DVT).
This description comes directly from the study's public registry record.
Marc Carrier, MD,MSc,FRCPC · 6137378899 · mcarrier@toh.ca
Always discuss trial participation with your own doctor first.
| The Ottawa Hospital General Campus | Ottawa, Ontario, Canada | Recruiting |
| Windsor Regional Hospital | Windsor, Ontario, Canada | Recruiting |
| Centre de recherche du Centre hospitalier de l'Université de Montréal | Montreal, Quebec, Canada | Recruiting |
| The Sir Mortimer B. Davis Jewish General Hospital | Montreal, Quebec, Canada | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06440694